Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver

Thrombosis and Haemostasis

Volumn 80, Issue 1, 1998, Pages 128-133

  Cain, Dean ^a   Hutson, Susan M ^a   Wallin, Reidar ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; MENADIONE EPOXIDE; OXIDOREDUCTASE; WARFARIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG RESISTANCE; ENZYME ACTIVITY; GENE MUTATION; GENETIC RESISTANCE; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RAT;

EID: 0031902529     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615151     Document Type: Article

References (33)

1. Suttie JW. Vitamin K-dependent carboxylase. Ann Rev Biochem 1985; 54: 459-77.
2. Furie B, Furie C. The molecular basis of blood coagulation. Cell 1988; 53: 505-18.
3. Suttie JW. Vitamin K. In: Handbook of lipid research. Deluca HF, ed. New York: Plenum Press 1978; pp 211-77.
4. Wallin R, Martin LF. Warfarin poisoning and vitamin K antagonism in rat and human liver; design of a system in vitro that mimics the system in vivo. Biochem J 1987; 241: 389-96.
5. Wallin R, Gebhardt O, Prydz H. NAD(P)H dehydrogenase and its role in the vitamin K-dependent carboxylation reaction. Biochem J 1978; 169: 95-101.
6. Wallin R, Martin LF. Vitamin K-dependent carboxylation and vitamin K metabolism in liver: effects of warfarin. J Clin Invest 1985; 76: 1879-84.
7. Suttie JW. The biochemical basis of warfarin therapy. In: Advances in Experimental Medicine and Biology. Wessler S, Becker CG, Nemerson Y, eds. New York: Plenum Press 1987; pp 3-16.
8. Hirsh J, Dalen JE, Deykin D, Poller L. Oral Anticoagulants; Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. Chest 1992; 102: 312S-26S.
9. O'Reilly RA, Aggeler PM, Hoag MS, et al. Hereditary transmission of exceptional resistance to coumarin anticoagulant drugs. N Engl J Med 1983; 308: 1229-30.
10. Alving BM, Strickler MP, Knight RD, et al. Hereditary warfarin resistance. Arch Intern Med 1985; 145: 499-501.
11. Meehan AP. In: Rats and Mice, their Biology and Control. Meehan AP, ed. Mentokil Limited, Felcourt, East Grinstead, W. Sussex RH19 2JY, 1984.
12. Hadler MR, Stadbolt RS. Novel 4-hydroxycoumarin anticoagulants active against resistant rats. Nature 1988; 253: 275-7.
13. Fasco MJ, Principe LM, Walsh WA, Friedman PA. Warfarin inhibition of Vitamin K 2,3-epoxide reductase in rat liver. Biochemistry 1983; 22: 5655-60.
14. Lee JJ, Fasco M. Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfide. Biochemistry 1984; 23: 2246-52.
15. Hildebrandt EF, Suttie JW. Mechanism of Coumarin Action: Sensitivity of Vitamin K Metabolizing Enzymes of Normal and Warfarin-Resistant Rats. Biochemistry 1982; 21: 2406-11.
16. Wallin R, Guenthner TM. Purification of Warfarin-Sensitive Vitamin K Epoxide Reductase. Met Enzymol 1997; 282: 395-403.
17. Cain D, Hutson SM, Wallin R. Assembly of the Warfarin Sensitive Vitamin K 2,3-Epoxide Reductase Enzyme Complex in the Endoplasmic Reticulum Membrane. J Biol Chem 1997; 272: 29068-75.
18. Tishler M, Fieser LF, Wender NL. Hydro oxide and other derivatives of vitamin K1 and related compounds. J Amer Chem Soc 1940; 62: 2866-71.
19. Andersson C, Piemonte F, Mosialou E, Weinander R, Sun T-H, Lundquist G, Adang AEP, Morgenstern R. Kinetic studies on rat liver microsomal glutathione transferase: consequences of activation. Biochem Biophys Acta 1995; 1247: 277.
20. Wallin R, Culp E, Coleman DB, Goodman SR. A structural model of human erythrocyte band 2.1: Alignmemt of chemical and functional domains. Proc Natl Acad Sci USA 1984; 81: 4095-9.
21. Porter TD, Beck TW, Kasper CB. Complementary DNA and Amino Acid Sequence of Rat Liver Microsomal, Xenobiotic Epoxide Hydrolase. Arch Biochem Biophys 1986; 248: 121-9.
22. Laemmli UK. Cleavage of structured proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
23. Wallin R, Patrick SD, Martin L. Rat and Human Liver Vitamin K Epoxide Reductase: Inhibition by Thiol Blockers and Vitamin K1. Int J Biochem 1987; 19: 1063-8.
24. Chen CJ, Traugh JA. Expression of recombinant elongation factor 1 rabbit in Escherichia coli. Phosphorylation by casein kinase II. Biochim Biophys Acta 1995; 1264: 303-11.
25. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: Regulation of GST and the Contribution of the Isoenzymes to Cancer Chemoprotection and Drug Resistance. Crit Rev Biochem Mol Biol 1995; 30: 446-800.
26. Jackson WB, Ashton AD, Delventhal K. Overview of anticoagulant rodenticide usage and resistance. In: Current Advances in Vitamin K Research. Suttie JW, ed., New York: Elsevier 1988; pp 381-8.
27. Ansell JE. Oral anticoagulant therapy - 50 years later. Arch Intern Med 1993; 153: 586-96.
28. Seidegard J, Depierre JW. Microsomal epoxide hydrolase: properties, regulation and function. Biochim Biophys Acta 1983; 695: 251-70.
29. Alves C, Von Dippe P, Amoui M, Levy D. Bile acid transport into hepatocytes smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations. J Biol Chem 1990; 268: 20148-55.
30. Thijssen HHW, Baars LGM. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase. Biochem Pharmacol 1989; 38: 1115-20.
31. Abramovitz M, Wong E, Cox ME, Richardson CD, Li C, Vickers PJ. 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem 1993; 215: 105-11.
32. Morgenstern R, Guthenberg C, Mannervik B, DePierre JW. The amount and nature of glutathione transferases in rat liver microsomes determined by immunochemical methods. FEBS Lett 1983; 160: 264-8.
33. Wu S-M, Morris DP, Stafford DW. Identification and purification to near homogeneity of the vitamin K-dependent carboxylase. Proc Natl Acad Sci USA 1991; 88: 2236-40.